---
figid: PMC138693__bcr312-2
figlink: /pmc/articles/PMC138693/figure/F2/
number: F2
caption: Phosphoinositide 3-kinase (PI3K) signalling and cancer. Schematic signalling
  pathway indicating the interactions that occur between known breast cancer oncogenes
  (ErbB2, Src) and tumour suppressors (PTEN, BRCA1) with components of the PI3K signalling
  cassette. Direct physical interactions are shown with solid arrows. Processes involving
  several steps are indicated with a dashed arrow; +, an activation step. Blunt arrows
  indicate inhibitory effects. Akt, Protein kinase B; ATM, ataxia telangiectasia mutated;
  ER, oestrogen receptor; 3-Ptase and 5-Ptase, phosphoinositide 3-phosphatase and
  phosphoinositide 5-phosphatase activities; PTEN, phosphatase and tensin homolog
  deleted on chromosome 10; TOR, target of rapamycin.
pmcid: PMC138693
papertitle: 'Phosphoinositide 3-kinase signalling in breast cancer: how big a role
  might it play?.'
reftext: Michael John Fry. Breast Cancer Res. 2001;3(5):304-312.
pmc_ranked_result_index: '5467'
pathway_score: 0.9256951
filename: bcr312-2.jpg
figtitle: Phosphoinositide 3-kinase (PI3K) signalling and cancer
year: '2001'
organisms:
- Homo sapiens
ndex: 276b9e79-df0b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC138693__bcr312-2.html
  '@type': Dataset
  description: Phosphoinositide 3-kinase (PI3K) signalling and cancer. Schematic signalling
    pathway indicating the interactions that occur between known breast cancer oncogenes
    (ErbB2, Src) and tumour suppressors (PTEN, BRCA1) with components of the PI3K
    signalling cassette. Direct physical interactions are shown with solid arrows.
    Processes involving several steps are indicated with a dashed arrow; +, an activation
    step. Blunt arrows indicate inhibitory effects. Akt, Protein kinase B; ATM, ataxia
    telangiectasia mutated; ER, oestrogen receptor; 3-Ptase and 5-Ptase, phosphoinositide
    3-phosphatase and phosphoinositide 5-phosphatase activities; PTEN, phosphatase
    and tensin homolog deleted on chromosome 10; TOR, target of rapamycin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - ERBB3
  - ERBB2
  - HRAS
  - SRC
  - ATM
  - RORC
  - ERBB4
  - CCND2
  - CCND1
  - CCND3
  - BRCA1
  - PTK6
  - PIK3R5
  - AKT1
  - PIK3R4
  - PDK1
  - NRAS
  - AKT2
  - AKT3
  - PIK3CD
  - PIK3R6
  - KRAS
  - PTEN
  - PIK3CG
  - PIK3CB
  - PIK3CA
  - INPP5A
  - PIK3R3
  - Ly294002
  - Rapamycin
  - Cancer
  - Lung cancer
genes:
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: c-Src
  symbol: c-src
  source: hgnc_alias_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: ATM
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: TOR
  symbol: TOR
  source: hgnc_alias_symbol
  hgnc_symbol: RORC
  entrez: '6097'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: BRCA1
  symbol: BRCA1
  source: hgnc_symbol
  hgnc_symbol: BRCA1
  entrez: '672'
- word: BRK
  symbol: BRK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK6
  entrez: '5753'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: -PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PIK3CA
  symbol: PIK3CA
  source: hgnc_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: 5-Ptase
  symbol: 5PTASE
  source: hgnc_alias_symbol
  hgnc_symbol: INPP5A
  entrez: '3632'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
chemicals:
- word: Ly294002
  source: MESH
  identifier: C085911
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC138693__F2
redirect_from: /figures/PMC138693__F2
figtype: Figure
---
